风湿科医生供给与多学科诊疗与患者及时获得风湿科诊疗的关联:来自加拿大不列颠哥伦比亚省的证据
研究利用不列颠哥伦比亚省纵向数据库分析2010-2011至2019-2020年风湿科医生接诊与处方数据,期间新发风湿科就诊149,902次,2019-2020年较2010-2011年增加31%。转诊至首次就诊中位时间从63天(四分位距21-120天)缩短22天(35%),类风湿关节炎患者转诊至首次改善病情抗风湿药时间缩短4天(6%)至62天。男性、居住于大都市区及由使用多学科诊疗评估代码的风湿科医生接诊与更短的转诊至首次改善病情抗风湿药时间相关。
要点
- 转诊至首次风湿科就诊中位时间从63天(四分位距21-120天)缩短22天(35%)。
- 类风湿关节炎患者转诊至首次改善病情抗风湿药时间缩短4天(6%)至62天。
- 男性、居住于大都市区及由使用多学科诊疗评估代码的风湿科医生接诊与更短的转诊至首次改善病情抗风湿药时间相关。
核心结论
- 风湿科诊疗可及性改善,首诊中炎症性关节炎患者比例增加提示风湿科医生供给与多学科诊疗激励可能改善了转诊模式。
- 类风湿关节炎患者获得改善病情抗风湿药的时间仍然较长,并发现女性患者及居住于大都市区以外人群存在可及性不平等的信号。
研究设计与样本
- 研究访问了Population Data BC纵向数据库,该数据库包含加拿大不列颠哥伦比亚省所有居民去标识化的个体水平健康数据。
- 分析了2010-2011年至2019-2020年的医生就诊与处方数据。
- 以转诊至首次风湿科就诊时间计算可及性,对类风湿关节炎患者另计算至首次改善病情抗风湿药的时间。
- 采用分位数回归探索滞后时间、患者特征与系统变量之间的关联。
主要发现
- 研究期间新发风湿科就诊共149,902次,2019-2020年较2010-2011年就诊次数增加31%。
- 首诊中炎症性关节炎患者比例从28%上升至51%。
- 转诊至首次就诊中位时间从2010-2011年的63天(四分位距21-120天)缩短22天(35%)。
- 类风湿关节炎患者转诊至首次改善病情抗风湿药时间缩短4天(6%)至62天。
- 男性、居住于大都市区及由使用多学科诊疗评估代码的风湿科医生接诊与更短的转诊至首次改善病情抗风湿药时间相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective was to understand how the expansion of rheumatology supply and the introduction of multidisciplinary care was associated with access to rheumatology services. METHODS: We accessed Population Data BC, a longitudinal database with de-identified individual-level health data on all residents of British Columbia, Canada, to analyze physician visits and prescribing from 2010-2011 to 2019-2020. We calculated access as the time from referral to first rheumatologist visit and, for people with rheumatoid arthritis (RA), time to first disease-modifying antirheumatic drug (DMARD). Associations between lag time, patient characteristics, and system variables were explored using quantile regression. RESULTS: Over the study period, there were 149,902 new rheumatologist visits, with 31% more visits in 2019-2020 than in 2010-2011. The proportion of first visits for patients with inflammatory arthritis increased from 28% to 51%. The median time from referral to first visit decreased by 22 days (35%) from 63 days (interquartile range 21-120 days) in 2010-2011. For people with RA, time from referral to DMARD decreased by 4 days (6%) to 62 days. Male sex, living in metropolitan areas, and having a rheumatologist who used a multidisciplinary care assessment code were associated with shorter times from referral to first DMARD. CONCLUSION: Access to rheumatology care improved, and the increased proportion of patients with IA in the first visits case-mix indicates that rheumatologist supply and incentives for multidisciplinary care may have improved referral patterns. However, time to DMARDs for people with RA remained long, and we found signals of unequal access for female patients and people living outside of metropolitan areas.
引用
- Biln NK, Guh D, Bansback N, et al. The Association of Rheumatologist Supply and Multidisciplinary Care With Timely Patient Access to Rheumatologists: Evidence From British Columbia, Canada. Arthritis Care Res (Hoboken). 2024. PMID: 38018333. doi:10.1002/acr.25274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。